TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives August 29, 1975